Advertisement
UK markets close in 48 minutes
  • FTSE 100

    8,312.52
    +99.03 (+1.21%)
     
  • FTSE 250

    20,379.01
    +214.47 (+1.06%)
     
  • AIM

    775.79
    +4.26 (+0.55%)
     
  • GBP/EUR

    1.1650
    -0.0009 (-0.08%)
     
  • GBP/USD

    1.2554
    -0.0010 (-0.08%)
     
  • Bitcoin GBP

    50,368.44
    -573.53 (-1.13%)
     
  • CMC Crypto 200

    1,312.42
    -52.71 (-3.86%)
     
  • S&P 500

    5,188.25
    +7.51 (+0.14%)
     
  • DOW

    38,938.91
    +86.64 (+0.22%)
     
  • CRUDE OIL

    77.93
    -0.55 (-0.70%)
     
  • GOLD FUTURES

    2,328.50
    -2.70 (-0.12%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,375.78
    +200.57 (+1.10%)
     
  • CAC 40

    8,056.08
    +59.44 (+0.74%)
     

Tate & Lyle alters European joint venture, Splenda business

(Repeats to attach to Reuters alerts)

LONDON, April 21 (Reuters) - Tate & Lyle (LSE: TATE.L - news) on Tuesday said it would exit most of its European bulk ingredients business and restructure its struggling Splenda sucralose business, in a bid to focus on and strengthen its specialty food ingredients business.

Regarding a European corn wet-milling joint venture the company has with Archer Daniels Midland, Tate said it would exit the bulk ingredients plants in Bulgaria, Turkey and Hungary and take full ownership of a more specialty-focused plant in Slovakia.

It also said it would consolidate production of all its Splenda sucralose at a facility in Alabama and close a Singapore facility in the spring of 2016. (Reporting by Martinne Geller; Editing by David Holmes)